Cipta Sarana Medika Tbk. vs Nanotech Indonesia Global Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Nanotech Indonesia Global Tbk. trades at Rp28 (market cap 111.42B, 52.05M 24h volume). The key difference: Cipta Sarana Medika Tbk. is the larger of the two by market cap, and Nanotech Indonesia Global Tbk. is more actively traded (52.05M versus 8.21M). Which is the better fit depends on your goals.
| DKHH | NANO | |
|---|---|---|
Market Cap | 158.12B | 111.42B |
Volume | 8.21M | 52.05M |
Lot | 82.15K | 520.51K |
Turnover | 515.2M | 1.44B |
Average Price | 62.72 | 27.67 |
Value | 515.2M | 1.44B |
Indicative Equilibrium Price | 63 | 28 |
Indicative Equilibrium Volume | 1.33K | 115 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Nanotech Indonesia Global Tbk (the Company) was established on May 22, 2019 based on the Notarial Deed No. 374 of Nurlisa Uke Desy, S.H. M.Kn. The Company has operated since 2019.
Read more on NANO →